1243 related articles for article (PubMed ID: 26776441)
1. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK
Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111
[TBL] [Abstract][Full Text] [Related]
3. Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis.
Moore SM; Khalaj AJ; Kumar S; Winchester Z; Yoon J; Yoo T; Martinez-Torres L; Yasui N; Katzenellenbogen JA; Tiwari-Woodruff SK
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18061-6. PubMed ID: 25453074
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Khalaj AJ; Yoon J; Nakai J; Winchester Z; Moore SM; Yoo T; Martinez-Torres L; Kumar S; Itoh N; Tiwari-Woodruff SK
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19125-30. PubMed ID: 24191028
[TBL] [Abstract][Full Text] [Related]
5. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
6. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.
Crawford DK; Mangiardi M; Song B; Patel R; Du S; Sofroniew MV; Voskuhl RR; Tiwari-Woodruff SK
Brain; 2010 Oct; 133(10):2999-3016. PubMed ID: 20858739
[TBL] [Abstract][Full Text] [Related]
8. Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis.
Karim H; Kim SH; Lauderdale K; Lapato AS; Atkinson K; Yasui N; Yamate-Morgan H; Sekyi M; Katzenellenbogen JA; Tiwari-Woodruff SK
Sci Rep; 2019 Jan; 9(1):503. PubMed ID: 30679747
[TBL] [Abstract][Full Text] [Related]
9. Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.
Karim H; Kim SH; Lapato AS; Yasui N; Katzenellenbogen JA; Tiwari-Woodruff SK
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6291-6296. PubMed ID: 29844175
[TBL] [Abstract][Full Text] [Related]
10. Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.
Yamate-Morgan H; Lauderdale K; Horeczko J; Merchant U; Tiwari-Woodruff SK
Neuroscience; 2019 May; 406():667-683. PubMed ID: 30703503
[TBL] [Abstract][Full Text] [Related]
11. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
12. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
13. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
14. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.
Voskuhl RR; Itoh N; Tassoni A; Matsukawa MA; Ren E; Tse V; Jang E; Suen TT; Itoh Y
Proc Natl Acad Sci U S A; 2019 May; 116(20):10130-10139. PubMed ID: 31040210
[TBL] [Abstract][Full Text] [Related]
17. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Xiao L; Guo D; Hu C; Shen W; Shan L; Li C; Liu X; Yang W; Zhang W; He C
Glia; 2012 Jul; 60(7):1037-52. PubMed ID: 22461009
[TBL] [Abstract][Full Text] [Related]
18. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice.
Sun JJ; Ren QG; Xu L; Zhang ZJ
Sci Rep; 2015 Sep; 5():14235. PubMed ID: 26383267
[TBL] [Abstract][Full Text] [Related]
19. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
[TBL] [Abstract][Full Text] [Related]
20. Remyelinating strategies in multiple sclerosis.
Luessi F; Kuhlmann T; Zipp F
Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
